![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Decision-Analytic Markov Model to Evaluate the Health Outcomes of Ledipasvir/Sofosbuvir for Patients with Chronic Hepatitis C Genotype 1 Infection
|
|
|
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Zobair M Younossi1,2, Sammy Saab3, Aijaz Ahmed4, Stuart C. Gordon5
1Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, VA; 2.Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA; 3.University of California Los Angeles, Los Angeles, CA; 4.Stanford University, Stanford, CA; 5.Henry Ford Hospital, Detroit, MI
![AASLD1.gif](../images/111714/111714-3/AASLD1.gif)
![AASLD2.gif](../images/111714/111714-3/AASLD2.gif)
![AASLD3.gif](../images/111714/111714-3/AASLD3.gif)
![AASLD4.gif](../images/111714/111714-3/AASLD4.gif)
![AASLD5.gif](../images/111714/111714-3/AASLD5.gif)
![AASLD6.gif](../images/111714/111714-3/AASLD6.gif)
![AASLD7.gif](../images/111714/111714-3/AASLD7.gif)
![AASLD8.gif](../images/111714/111714-3/AASLD8.gif)
![AASLD9.gif](../images/111714/111714-3/AASLD9.gif)
![AASLD10.gif](../images/111714/111714-3/AASLD10.gif)
![AASLD11.gif](../images/111714/111714-3/AASLD11.gif)
![AASLD12.gif](../images/111714/111714-3/AASLD12.gif)
![AASLD13.gif](../images/111714/111714-3/AASLD13.gif)
![AASLD14.gif](../images/111714/111714-3/AASLD14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|